Cytosorbents (CTSO) Other Operating Expenses (2010 - 2026)
Cytosorbents' (CTSO) quarterly Other Operating Expenses came in at -$6.6 million in Q1 2026, up 5.12% YoY from -$6.2 million in Q1 2025, and down 129.09% on a QoQ basis from $22.5 million in Q4 2025.
Cytosorbents (CTSO) Other Operating Expenses (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Other Operating Expenses data on file, last reported at -$6.6 million in Q1 2026.
- Quarterly Other Operating Expenses rose 5.12% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (up 118.04% YoY) and the FY2025 annual result came in at $2.1 million, up 109.11% from the prior year.
- Other Operating Expenses eased to -$6.6 million in Q1 2026, from $22.5 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $22.5 million in Q4 2025 to a low of -$6.9 million in Q1 2024.
- A 5-year average of -$1.4 million and a median of -$3.4 million in 2023 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2024 — Other Operating Expenses sank 1276.29% — and 2025, when it jumped 691.04%.
- Tracing CTSO's Other Operating Expenses over 5 years: stood at $758569.0 in 2022, then plunged by 548.51% to -$3.4 million in 2023, then fell by 12.07% to -$3.8 million in 2024, then jumped by 691.04% to $22.5 million in 2025, then plunged by 129.09% to -$6.6 million in 2026.
- The last three Other Operating Expenses figures came in at -$6.6 million (Q1 2026), $22.5 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.99 Mn | 17.58 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30,000.00 |
| Mar 31, 2026 | -6.56 Mn |
| Dec 31, 2025 | 22.54 Mn |
| Sep 30, 2025 | -5.97 Mn |
| Jun 30, 2025 | -5.83 Mn |
| Mar 31, 2025 | -6.91 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -6.26 Mn |
| Jun 30, 2024 | -6.22 Mn |
| Mar 31, 2024 | -6.93 Mn |
| Dec 31, 2023 | -3.40 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 589,294.00 |
| Dec 31, 2022 | 758,569.00 |
| Sep 30, 2022 | 609,518.00 |
| Jun 30, 2022 | 679,077.00 |
| Mar 31, 2022 | 800,735.00 |
| Dec 31, 2021 | 641,205.00 |
| Sep 30, 2021 | 664,689.00 |